|
|
Volumn 83, Issue 2, 1999, Pages 525-536
|
|
Novel drugs for Parkinson's disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
3 (3 HYDROXY 4 PIVALOYLOXYPHENYL)ALANINE;
3 ETHYNYL 5 (1 METHYL 2 PYRROLIDINYL)PYRIDINE;
ANTIPARKINSON AGENT;
DECARBOXYLASE INHIBITOR;
DOPAMINE RECEPTOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
GLUTAMATE RECEPTOR ANTAGONIST;
LAZABEMIDE;
LEVODOPA;
MONOAMINE OXIDASE B INHIBITOR;
NEURITE PROMOTING FACTOR;
NEUROTROPHIC FACTOR;
NEW DRUG;
NICOTINIC AGENT;
RASAGILINE;
SCAVENGER;
SELEGILINE;
TOCOPHEROL;
UNCLASSIFIED DRUG;
CONSERVATIVE TREATMENT;
DRUG BIOAVAILABILITY;
DRUG EFFECT;
DRUG SCREENING;
DYSKINESIA;
HUMAN;
PARKINSON DISEASE;
PATIENT CARE;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
SUBCUTANEOUS DRUG ADMINISTRATION;
SYMPTOMATOLOGY;
TREATMENT PLANNING;
|
|
EID: 0033038259
PISSN: 00257125
EISSN: None
Source Type: Journal
DOI: 10.1016/S0025-7125(05)70118-8 Document Type: Article |
|
Times cited : (11)
|
|
References (37)
|
